Form 4: HeartBeam President Eno Granted 24,242 RSUs

HeartBeam, Inc. President Robert Paul Eno was granted 24,242 Restricted Stock Units (RSUs) under the company's 2022 Equity Incentive Plan.

Summary

• Robert Paul Eno, President of HeartBeam, Inc. (BEAT), received a grant of 24,242 Restricted Stock Units (RSUs).
• The RSUs were granted on September 30, 2025, with a vesting commencement date of July 1, 2025.
• One half of the total RSUs (12,121 shares) will vest on the three-month anniversary of the vesting commencement date, which is October 1, 2025.
• The remaining half of the RSUs (12,121 shares) will vest on the six-month anniversary of the vesting commencement date, which is January 1, 2026.
• These RSUs were issued from the company's 2022 Equity Incentive Plan.
• The transaction price for the RSU grant was $0, which is typical for equity awards.

Sentiment

Score: 6

Explanation: Slightly positive as it aligns executive incentives with shareholder value and is a routine compensation practice, indicating stability in management compensation strategy. No significant negative implications beyond minor future dilution.

Positives

• Aligns management's interests with long-term shareholder value through equity incentives.
• Serves as a retention mechanism for a key executive, the President.
• Utilizes the company's established 2022 Equity Incentive Plan for compensation, indicating a structured approach to executive rewards.

Negatives

• Potential for future dilution of existing shareholders upon the vesting and conversion of RSUs into common stock.

Risks

• Future dilution of existing shareholders when the 24,242 RSUs vest and convert into common stock.
• Dependence on the continued performance and retention of key executives like the President for the company's strategic execution.

Future Outlook

The future outlook involves the vesting of 24,242 Restricted Stock Units for President Robert Paul Eno, with half vesting on October 1, 2025, and the remainder on January 1, 2026, aligning his incentives with the company's long-term performance.

Management Comments

• "Granted Restricted Stock Units (RSU's) on September 30, 2025, one half of the total number of Shares subject to the Special RSU shall vest on the three-month anniversary of the vesting commencement date (July 1, 2025) and the remaining Shares subject to the Special RSU shall vest on the six-month anniversary of the vesting commencement date."
• "These RSUs have been issued from the Company's 2022 Equity Incentive Plan."
• "RSUs do not expire, they either vest or are canceled prior to vesting date."

Industry Context

The grant of Restricted Stock Units to a key executive like the President is a standard practice in the technology and healthcare industries for executive compensation, aiming to incentivize long-term performance and retain talent. This aligns HeartBeam with common corporate governance practices for public companies.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) for executive compensation is a common practice across publicly traded companies, particularly in growth-oriented sectors like medical technology.
• Vesting schedules, such as the 3-month and 6-month anniversaries from a commencement date, are typical for short-to-medium term incentive structures, though longer vesting periods (e.g., 3-4 years) are also prevalent for broader equity grants.
• The grant size of 24,242 shares for a President would need to be benchmarked against similar roles in companies of comparable market capitalization and stage of development within the medical device or digital health industry to assess its relative scale, but the filing does not provide such comparative data.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential minor dilution upon vesting of RSUs, but also benefit from incentivized executive performance.
• Employees: Demonstrates the company's commitment to equity-based compensation, potentially boosting morale and retention for other employees.
• Management: Provides a significant equity incentive and retention mechanism for the President.

Next Steps

• Vesting of 12,121 RSUs on October 1, 2025.
• Vesting of 12,121 RSUs on January 1, 2026.

Key Dates

Recommendation

This Form 4 filing reports a routine grant of Restricted Stock Units to a key executive, which is a standard compensation practice. It does not contain any information that would fundamentally alter the company's financial outlook or operational performance, nor does it suggest any immediate catalysts for significant share price movement. Therefore, a 'hold' recommendation is appropriate as it reflects a neutral event in the company's ongoing operations.

Keywords

HeartBeam, BEAT, Robert Paul Eno, Restricted Stock Units, RSU, Equity Incentive Plan, Insider Transaction, Executive Compensation, Form 4